Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record’s latest submission and posting dates were updated from July 2026 to November 2026, alongside a minor ClinicalTrials.gov site revision update.
    Difference
    0.1%
    Check dated 2026-11-18T11:44:57.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The study record for a Phase 3 comparison of selumetinib alone versus selumetinib with vinblastine is displayed, including treatment arms, eligibility criteria, outcomes, and study locations.
    Difference
    100%
    Check dated 2026-11-11T14:00:16.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision number also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T13:58:05.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T14:58:57.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now returns a 403 Forbidden error, replacing the study record content. The detailed study information (title, conditions, locations, eligibility, and plans) has been removed, leaving only generic site chrome and footer text.
    Difference
    21%
    Check dated 2026-09-23T20:26:25.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0. This indicates a new version of the page used for internal tracking, with no explicit changes to the study content evident from the provided data.
    Difference
    0.0%
    Check dated 2026-09-16T22:19:51.000Z thumbnail image

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.